Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Clin Lab Med ; 21(3): 435-73, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11572137

ABSTRACT

Concern regarding the use of biological agents (bacteria, viruses, or toxins) as tools of warfare or terrorism has led to measures to deter their use or, failing that, to deal with the consequences. Unlike chemical agents, which typically lead to severe disease syndromes within minutes at the site of exposure, diseases resulting from biological agents have incubation periods of days. Rather than a paramedic, it will likely be a physician who is first faced with evidence of the results of a biological attack. Provided here is an updated primer on 11 classic BW and potential terrorist agents to increase the likelihood of their being considered in a differential diagnosis. Although the resultant diseases are rarely seen in many countries today, accepted diagnostic and epidemiologic principles apply; if the cause is identified quickly, appropriate therapy can be initiated and the impact of a terrorist attack greatly reduced.


Subject(s)
Biological Warfare , Communicable Diseases/diagnosis , Communicable Diseases/therapy , Humans
2.
Mil Med ; 165(9): 659-62, 2000 Sep.
Article in English | MEDLINE | ID: mdl-11011535

ABSTRACT

Warriors on the modern battlefield face considerable danger from possible attack with chemical and biological weapons. Aggravating this danger is the fact that medical resources at the lowest echelons of care, already likely to be strained to capacity during modern conventional combat, are at present inadequate to handle large numbers of chemical or biological casualties. Complicating this problem further is the austere nature of diagnostic modalities available at lower echelons. With this in mind, and given the urgency required to adequately manage chemical and biological casualties, it is likely that such casualties will initially require significant empiric care in the absence of a definitive diagnosis. Such care under field conditions, often rendered by relatively inexperienced medical personnel, might best be provided using an algorithmic approach. We have developed such an algorithm.


Subject(s)
Algorithms , Biological Warfare , Chemical Warfare , Emergency Treatment/methods , Military Medicine/methods , Nervous System Diseases , Respiratory Tract Diseases , Decision Trees , Humans , Nervous System Diseases/diagnosis , Nervous System Diseases/etiology , Nervous System Diseases/therapy , Respiratory Tract Diseases/diagnosis , Respiratory Tract Diseases/etiology , Respiratory Tract Diseases/therapy , Time Factors
3.
Clin Infect Dis ; 30(6): 843-50, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10880299

ABSTRACT

The intentional release of biological agents by belligerents or terrorists is a possibility that has recently attracted increased attention. Law enforcement agencies, military planners, public health officials, and clinicians are gaining an increasing awareness of this potential threat. From a military perspective, an important component of the protective pre-exposure armamentarium against this threat is immunization. In addition, certain vaccines are an accepted component of postexposure prophylaxis against potential bioterrorist threat agents. These vaccines might, therefore, be used to respond to a terrorist attack against civilians. We review the development of vaccines against 10 of the most credible biological threats.


Subject(s)
Bacterial Vaccines , Biological Warfare/prevention & control , Immunization , Viral Vaccines , Bacterial Infections/prevention & control , Bacterial Vaccines/administration & dosage , Humans , Viral Vaccines/administration & dosage , Virus Diseases/prevention & control
4.
JAMA ; 283(2): 242-9, 2000 Jan 12.
Article in English | MEDLINE | ID: mdl-10634341

ABSTRACT

Biological and chemical terrorism is a growing concern for the emergency preparedness community. While health care facilities (HCFs) are an essential component of the emergency response system, at present they are poorly prepared for such incidents. The greatest challenge for HCFs may be the sudden presentation of large numbers of contaminated individuals. Guidelines for managing contaminated patients have been based on traditional hazardous material response or military experience, neither of which is directly applicable to the civilian HCF. We discuss HCF planning for terrorist events that expose large numbers of people to contamination. Key elements of an effective HCF response plan include prompt recognition of the incident, staff and facility protection, patient decontamination and triage, medical therapy, and coordination with external emergency response and public health agencies. Controversial aspects include the optimal choice of personal protective equipment, establishment of patient decontamination procedures, the role of chemical and biological agent detectors, and potential environmental impacts on water treatment systems. These and other areas require further investigation to improve response strategies.


Subject(s)
Biological Warfare , Chemical Warfare , Disaster Planning/standards , Health Facility Planning/organization & administration , Decontamination , Guidelines as Topic , Health Facility Planning/standards , Humans , Organizational Objectives , Patient Admission , Protective Devices , Security Measures , Triage , United States
5.
Mil Med ; 165(11 Suppl): 1-21, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11143422

ABSTRACT

A basic understanding of the transmission and isolation of infections would be essential to the safe and effective aeromedical evacuation (AE) of biological warfare (BW) casualties. First, the airframe as microbial environment is considered, and relevant preventive and disinfecting measures are discussed. A survey of past infectious disease transmission on civilian aircraft (including tuberculosis, influenza, measles, smallpox, and viral hemorrhagic fevers) is presented, and the communicability and stability of likely BW agents is described. A brief history of U.S. military aeromedical evacuation (as it relates to contagious diseases and U.S. Air Force BW doctrine) is also outlined. Special containment procedures (especially as used by the U.S. Army Aeromedical Isolation Team) are described. Finally, international legal and regulatory aspects of the AE of BW casualties are considered, and some unanswered questions and suggestions for future research are offered. It is concluded that, given adequate foresight, expertise, and resources, the AE of even contagious BW casualties could be safely and effectively accomplished.


Subject(s)
Aircraft/standards , Biological Warfare , Communicable Disease Control/organization & administration , Military Personnel , Adult , Air Ambulances/organization & administration , Air Ambulances/standards , Aircraft/legislation & jurisprudence , Communicable Disease Control/legislation & jurisprudence , Disease Transmission, Infectious/prevention & control , Female , Humans , Male , Rescue Work/organization & administration , Tuberculosis/transmission , United States , Ventilation , Virus Diseases/transmission
7.
Emerg Infect Dis ; 5(2): 241-6, 1999.
Article in English | MEDLINE | ID: mdl-10221876

ABSTRACT

Military contingency operations in tropical environments and potential use of biological weapons by adversaries may place troops at risk for potentially lethal contagious infections (e.g., viral hemorrhagic fevers, plague, and zoonotic poxvirus infections). Diagnosis and treatment of such infections would be expedited by evacuating a limited number of patients to a facility with containment laboratories. To safely evacuate such patients by military aircraft and minimize the risk for transmission to air crews, caregivers, and civilians, the U.S. Army Medical Research Institute of Infectious Diseases maintains an aeromedical isolation team. This rapid response team, which has worldwide airlift capability designed to evacuate and manage patients under high-level containment, also offers a portable containment laboratory, limited environmental decontamination, and specialized consultative expertise. This article also examines technical aspects of the team's equipment, training, capabilities, and deployments.


Subject(s)
Aircraft , Containment of Biohazards , Patient Isolators , Humans
8.
Arch Dermatol ; 135(3): 311-22, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10086453

ABSTRACT

The specter of biological warfare (BW) looms large in the minds of many Americans. The US government has required that emergency response teams in more than 100 American cities be trained by the year 2001 to recognize and contain a BW attack. The US military is requiring active duty soldiers to receive immunization against anthrax. Dermatologists need not feel helpless in the face of a potential BW attack. Many potential agents have cutaneous manifestations that the trained eye of a dermatologist can recognize. Through early recognition of a BW attack, dermatologists can aid public health authorities in diagnosing the cause so that preventive and containment measures can be instituted to mitigate morbidity and mortality. This article reviews bacterial, viral, and toxin threat agents and emphasizes those that would have cutaneous manifestations following an aerosol attack. We conclude with clues that can help one recognize a biological attack.


Subject(s)
Biological Warfare , Skin Diseases/diagnosis , Skin Diseases/etiology , Anthrax , Hemorrhagic Fevers, Viral , Humans , Melioidosis , Plague , Poxviridae Infections , Skin Diseases/microbiology , Skin Diseases/virology , Trichothecenes/toxicity , Tularemia , Vaccinia
10.
JAMA ; 278(5): 399-411, 1997 Aug 06.
Article in English | MEDLINE | ID: mdl-9244332

ABSTRACT

Concern regarding the use of biological agents--bacteria, viruses, or toxins--as tools of warfare or terrorism has led to measures to deter their use or, failing that, to deal with the consequences. Unlike chemical agents, which typically lead to violent disease syndromes within minutes at the site of exposure, diseases resulting from biological agents have incubation periods of days. Therefore, rather than a paramedic, it will likely be a physician who is first faced with evidence of the results of a biological attack. We provide here a primer on 10 classic biological warfare agents to increase the likelihood of their being considered in a differential diagnosis. Although the resultant diseases are rarely seen in many countries today, accepted diagnostic and epidemiologic principles apply; if the cause is identified quickly, appropriate therapy can be initiated and the impact of a terrorist attack greatly reduced.


Subject(s)
Biological Warfare , Communicable Diseases , Anthrax , Botulinum Toxins , Brucellosis , Communicable Diseases/diagnosis , Communicable Diseases/drug therapy , Communicable Diseases/epidemiology , Disease Outbreaks/prevention & control , Encephalitis, Viral , Enterotoxins , Hemorrhagic Fevers, Viral , Humans , Plague , Q Fever , Smallpox , Tularemia , Violence
11.
JAMA ; 278(5): 412-7, 1997 Aug 06.
Article in English | MEDLINE | ID: mdl-9244333

ABSTRACT

The deliberate use of microorganisms and toxins as weapons has been attempted throughout history. Biological warfare has evolved from the crude use of cadavers to contaminate water supplies to the development of specialized munitions for battlefield and covert use. The modern development of biological agents as weapons has paralleled advances in basic and applied microbiology. These include the identification of virulent pathogens suitable for aerosol delivery and industrial-scale fermentation processes to produce large quantities of pathogens and toxins. The history of biological warfare is difficult to assess because of a number of confounding factors. These include difficulties in verification of alleged or attempted biological attacks, the use of allegations of biological attacks for propaganda purposes, the paucity of pertinent microbiological or epidemiologic data, and the incidence of naturally occurring endemic or epidemic diseases during hostilities. Biological warfare has been renounced by 140 nations, primarily for strategic and other pragmatic reasons. International diplomatic efforts, including the 1972 Biological Weapons Convention, have not been entirely effective in preventing the enhancement and proliferation of offensive biological warfare programs. The threats posed by biological weapons are likely to continue into the future.


Subject(s)
Biological Warfare , Biological Warfare/legislation & jurisprudence , Disease Outbreaks , History, 18th Century , History, 19th Century , History, 20th Century , Humans , International Cooperation , Warfare
12.
Ann Allergy ; 70(5): 386-8, 1993 May.
Article in English | MEDLINE | ID: mdl-8498729

ABSTRACT

A 65-year-old woman with the acquired immunodeficiency syndrome (AIDS) complicated by recurrent mucocutaneous herpes simplex virus (HSV) infection developed angioedema on the initiation of her second course of oral acyclovir therapy. Oral rechallenge in hospital three days later confirmed acyclovir hypersensitivity. Vidarabine and foscarnet therapies were abandoned after treatment failure and unacceptable toxicity. Acyclovir desensitization was accomplished using a protocol derived from oral penicillin desensitization regimens. Mucocutaneous HSV infection responded to intravenous acyclovir followed by chronic oral suppression without recurrences of HSV or hypersensitivity. This report is an example of acyclovir hypersensitivity and successful oral desensitization.


Subject(s)
Acyclovir/immunology , Acquired Immunodeficiency Syndrome/complications , Acyclovir/administration & dosage , Acyclovir/adverse effects , Administration, Oral , Aged , Desensitization, Immunologic/methods , Drug Hypersensitivity/etiology , Female , Herpes Simplex/complications , Herpes Simplex/drug therapy , Humans , Skin Diseases, Infectious/complications , Skin Diseases, Infectious/drug therapy
14.
Arch Intern Med ; 145(10): 1908, 1985 Oct.
Article in English | MEDLINE | ID: mdl-3899040

ABSTRACT

A 67-year-old man with Escherichia coli bacteremia and meningitis was found to have hemochromatosis. To my knowledge this is the first documented case of E coli meningitis occurring in the setting of hemochromatosis. The case raises issues regarding the role of chronic liver disease in the pathogenesis of gram-negative sepsis and the impact of iron loading on host immunocompetence and bacterial virulence.


Subject(s)
Escherichia coli Infections/microbiology , Hemochromatosis/complications , Meningitis/etiology , Sepsis/etiology , Aged , Escherichia coli/pathogenicity , Humans , Male , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL
...